Funded with Support from

In this surgical video, Drs. Jessica Lee and Richard Kaplan use external drainage to manage a total retinal detachment in a patient with Coats disease.

Drs. Boss and Sears demonstrate a lens-sparing, PFO-assisted external drainage technique for a pediatric total exudative retinal detachment that avoids the need for a drainage retinotomy.

This paper describes the investigation, response and successful containment of an adenovirus outbreak in a NICU associated with contaminated handheld ophthalmologic equipment used during retinopathy of prematurity screening.

Dr. Tahira Scholle demonstrates the administration of a subretinal injection of Luxturna (voretigene neparvovec-ryzyl), the first FDA-approved gene therapy for inherited retinal disease.

This prospective, multicenter study compared ophthalmoscopy with telemedicine for diagnosing retinopathy of prematurity (ROP).

Retinoblastoma (Rb) is a primary intraocular cancer that develops in the eyes of young children most often under the age of 5 years.Access to the acueous humor AH of eyes with active Rb has enabled the first-ever genetic analyses of Rb tumors in situ (ie, without enucleation). This is the first time that retinoblastoma tumor DNA has been available from eyes before they were enucleated. [Please also see the interview with Dr. Berry at https://www.aao.org/interview/aqueous-humor-biopsy-retinoblastoma.]

Dr. Janice Law makes the case that there are clinical advantages to using bevacizumab including the larger molecule more easily staying in the eye and a longer half-life, which prolongs its effect.

Dr. David Morrison makes the case that, although cost is an issue when considering the use of ranibizumab, there are many benefits to its use.

A white female who presented at 7 months for nystagmus has been followed over a 16-year period and has had 2 examinations under anesthesia confirming her diagnosis of achromatopsia.